229 related articles for article (PubMed ID: 22583164)
1. Willingness to pay and quality of life in patients with rosacea.
Beikert FC; Langenbruch AK; Radtke MA; Augustin M
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):734-8. PubMed ID: 22583164
[TBL] [Abstract][Full Text] [Related]
2. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay and quality of life in patients with atopic dermatitis.
Beikert FC; Langenbruch AK; Radtke MA; Kornek T; Purwins S; Augustin M
Arch Dermatol Res; 2014 Apr; 306(3):279-86. PubMed ID: 23982630
[TBL] [Abstract][Full Text] [Related]
4. Health Related Quality of Life of Rosacea Patients in China Assessed by Dermatology Life Quality Index and Willingness to Pay.
Huang Y; Yan S; Xie H; Wang B; Zhao Z; Huang Y; Li J
Patient Prefer Adherence; 2022; 16():659-670. PubMed ID: 35283624
[TBL] [Abstract][Full Text] [Related]
5. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
Hu SW; Holt EW; Husni ME; Qureshi AA
Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
[TBL] [Abstract][Full Text] [Related]
6. Psychological Burden and Willingness to Pay Among Korean Rosacea Patients and Their Association With Rosacea Phenotype and Severity: A Multi-Center Cross-Sectional Study.
Woo YR; Kim S; Cho SH; Kim HS
J Cutan Med Surg; 2023 Nov; 27(6):601-607. PubMed ID: 37587799
[TBL] [Abstract][Full Text] [Related]
7. The quality of life impact of acne and rosacea compared to other major medical conditions.
Cresce ND; Davis SA; Huang WW; Feldman SR
J Drugs Dermatol; 2014 Jun; 13(6):692-7. PubMed ID: 24918559
[TBL] [Abstract][Full Text] [Related]
8. Impacts of skin disorders associated with facial discoloration on quality of life: Novel insights explaining discordance between life quality scores and willingness to pay.
Yang TT; Lan CE
J Cosmet Dermatol; 2022 Jul; 21(7):3053-3058. PubMed ID: 34706154
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.
Oh DY; Crawford B; Kim SB; Chung HC; McDonald J; Lee SY; Ko SK; Ro J
Asia Pac J Clin Oncol; 2012 Sep; 8(3):282-91. PubMed ID: 22898238
[TBL] [Abstract][Full Text] [Related]
10. Quality of life among Malaysian patients with vitiligo.
Wong SM; Baba R
Int J Dermatol; 2012 Feb; 51(2):158-61. PubMed ID: 22250623
[TBL] [Abstract][Full Text] [Related]
11. [Willingness to pay and quality of life in patients with Japanese-cedar pollinosis].
Kakutani C; Ogino S; Irifune M; Takeda M; Baba K
Arerugi; 2003 Jan; 52(1):7-14. PubMed ID: 12598717
[TBL] [Abstract][Full Text] [Related]
12. Willingness-to-Pay and Benefit-Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China.
Deng Q; Zhang SP; Deng YX; Liu FF; Shi W; Xie HF; Xiao Y; Huang YX; Li J
Patient Prefer Adherence; 2020; 14():1843-1852. PubMed ID: 33116428
[TBL] [Abstract][Full Text] [Related]
13. Effect of vitiligo on self-reported health-related quality of life.
Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and rosacea: pulsed dye laser impact.
Menezes N; Moreira A; Mota G; Baptista A
J Cosmet Laser Ther; 2009 Sep; 11(3):139-41. PubMed ID: 19462330
[TBL] [Abstract][Full Text] [Related]
15. The psychological impact of rosacea and the influence of current management options.
Moustafa F; Lewallen RS; Feldman SR
J Am Acad Dermatol; 2014 Nov; 71(5):973-80. PubMed ID: 24993600
[TBL] [Abstract][Full Text] [Related]
16. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
17. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
[TBL] [Abstract][Full Text] [Related]
18. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
Ethgen O; Tancredi A; Lejeune E; Kvasz A; Zegels B; Reginster JY
J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
Tang MM; Chang CC; Chan LC; Heng A
Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
[TBL] [Abstract][Full Text] [Related]
20. Willingness-to-Pay and Benefit-Cost Analysis of Botulinum Toxin for the Treatment of Rosacea in China: Findings from a Web-Based Survey.
Yang X; Ouyang Y; Deng Y; Xiao Y; Tang Y; Jian D; Li J; Xie H; Huang Y
Patient Prefer Adherence; 2021; 15():1197-1205. PubMed ID: 34113082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
